443 related articles for article (PubMed ID: 18386299)
1. Is the mu-oxo-mu-peroxodiiron intermediate of a ribonucleotide reductase biomimetic a possible oxidant of epoxidation reactions?
de Visser SP
Chemistry; 2008; 14(15):4533-41. PubMed ID: 18386299
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of the peroxodiiron(III) intermediate generated during oxygen activation by the W48A/D84E variant of ribonucleotide reductase protein R2 from Escherichia coli.
Baldwin J; Krebs C; Saleh L; Stelling M; Huynh BH; Bollinger JM; Riggs-Gelasco P
Biochemistry; 2003 Nov; 42(45):13269-79. PubMed ID: 14609338
[TBL] [Abstract][Full Text] [Related]
3. The effect and influence of cis-ligands on the electronic and oxidizing properties of nonheme oxoiron biomimetics. A density functional study.
de Visser SP; Nam W
J Phys Chem A; 2008 Dec; 112(50):12887-95. PubMed ID: 18616332
[TBL] [Abstract][Full Text] [Related]
4. Tetranuclear iron(III) complexes of an octadentate pyridine-carboxylate ligand and their catalytic activity in alkane oxidation by hydrogen peroxide.
Gutkina EA; Trukhan VM; Pierpont CG; Mkoyan S; Strelets VV; Nordlander E; Shteinman AA
Dalton Trans; 2006 Jan; (3):492-501. PubMed ID: 16395449
[TBL] [Abstract][Full Text] [Related]
5. Propene activation by the oxo-iron active species of taurine/alpha-ketoglutarate dioxygenase (TauD) enzyme. How does the catalysis compare to heme-enzymes?
de Visser SP
J Am Chem Soc; 2006 Aug; 128(30):9813-24. PubMed ID: 16866538
[TBL] [Abstract][Full Text] [Related]
6. What factors influence the ratio of C-H hydroxylation versus C=C epoxidation by a nonheme cytochrome P450 biomimetic?
de Visser SP
J Am Chem Soc; 2006 Dec; 128(49):15809-18. PubMed ID: 17147391
[TBL] [Abstract][Full Text] [Related]
7. Use of a chemical trigger for electron transfer to characterize a precursor to cluster X in assembly of the iron-radical cofactor of Escherichia coli ribonucleotide reductase.
Saleh L; Krebs C; Ley BA; Naik S; Huynh BH; Bollinger JM
Biochemistry; 2004 May; 43(20):5953-64. PubMed ID: 15147179
[TBL] [Abstract][Full Text] [Related]
8. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
Sharma PK; De Visser SP; Ogliaro F; Shaik S
J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
[TBL] [Abstract][Full Text] [Related]
9. Structural and spectroscopic characterization of (mu-hydroxo or mu-oxo)(mu-peroxo)diiron(III) complexes: models for peroxo intermediates of non-heme diiron proteins.
Zhang X; Furutachi H; Fujinami S; Nagatomo S; Maeda Y; Watanabe Y; Kitagawa T; Suzuki M
J Am Chem Soc; 2005 Jan; 127(3):826-7. PubMed ID: 15656607
[TBL] [Abstract][Full Text] [Related]
10. Metal-peroxo versus metal-oxo oxidants in non-heme iron-catalyzed olefin oxidations: computational and experimental studies on the effect of water.
Quiñonero D; Morokuma K; Musaev DG; Mas-Ballesté R; Que L
J Am Chem Soc; 2005 May; 127(18):6548-9. PubMed ID: 15869272
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and catalytic activity of mononuclear iron and (mu-Oxo)diiron complexes with the ligand 2,6-bis(N-methylbenzimidazol-2-yl)pyridine.
Wang X; Wang S; Li L; Sundberg EB; Gacho GP
Inorg Chem; 2003 Dec; 42(24):7799-808. PubMed ID: 14632495
[TBL] [Abstract][Full Text] [Related]
12. Peroxo-type intermediates in class I ribonucleotide reductase and related binuclear non-heme iron enzymes.
Jensen KP; Bell CB; Clay MD; Solomon EI
J Am Chem Soc; 2009 Sep; 131(34):12155-71. PubMed ID: 19663382
[TBL] [Abstract][Full Text] [Related]
13. Epoxidation and 1,2-dihydroxylation of alkenes by a nonheme iron model system - DFT supports the mechanism proposed by experiment.
Comba P; Rajaraman G
Inorg Chem; 2008 Jan; 47(1):78-93. PubMed ID: 18072762
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic iron-catalyzed asymmetric epoxidation of aromatic alkenes by using hydrogen peroxide.
Gelalcha FG; Anilkumar G; Tse MK; Brückner A; Beller M
Chemistry; 2008; 14(25):7687-98. PubMed ID: 18567024
[TBL] [Abstract][Full Text] [Related]
15. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation?
de Visser SP; Tahsini L; Nam W
Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895
[TBL] [Abstract][Full Text] [Related]
16. Density functional study of a micro-1,1-carboxylate bridged Fe(III)-O-Fe(IV) model complex. 2. Comparison with ribonucleotide reductase intermediate X.
Han WG; Lovell T; Liu T; Noodleman L
Inorg Chem; 2004 Jan; 43(2):613-21. PubMed ID: 14731023
[TBL] [Abstract][Full Text] [Related]
17. Functional models of nonheme diiron enzymes: reactivity of the μ-oxo-μ-1,2-peroxo-diiron(iii) intermediate in electrophilic and nucleophilic reactions.
Kripli B; Szávuly M; Csendes FV; Kaizer J
Dalton Trans; 2020 Feb; 49(6):1742-1746. PubMed ID: 31967142
[TBL] [Abstract][Full Text] [Related]
18. A density functional evaluation of an Fe(III)-Fe(IV) model diiron cluster: comparisons with ribonucleotide reductase intermediate X.
Han WG; Lovell T; Liu T; Noodleman L
Inorg Chem; 2003 Apr; 42(8):2751-8. PubMed ID: 12691585
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of molecular dioxygen towards a series of isostructural dichloroiron(III) complexes with tripodal tetraamine ligands: general access to mu-oxodiiron(III) complexes and effect of alpha-fluorination on the reaction kinetics.
Thallaj NK; Rotthaus O; Benhamou L; Humbert N; Elhabiri M; Lachkar M; Welter R; Albrecht-Gary AM; Mandon D
Chemistry; 2008; 14(22):6742-53. PubMed ID: 18561351
[TBL] [Abstract][Full Text] [Related]
20. (Mu-1,2-peroxo)diiron(III/III) complex as a precursor to the diiron(III/IV) intermediate X in the assembly of the iron-radical cofactor of ribonucleotide reductase from mouse.
Yun D; García-Serres R; Chicalese BM; An YH; Huynh BH; Bollinger JM
Biochemistry; 2007 Feb; 46(7):1925-32. PubMed ID: 17256972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
